Concanavalin A-induced liver injury triggers hepatocyte proliferation

Journal of Clinical Investigation

Volumn 101, Issue 9, 1998, Pages 1960-1969

  Trautwein, Christian ^a   Rakemann, Tim ^a   Malek, Nisar Peter ^a   Plümpe, Jörg ^a   Tiegs, Gisa ^b   Manns, Michael Peter ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Apoptosis; Cell cycle; Hepatocytes; Interleukin 6; Tumor necrosis factor

Indexed keywords

CONCANAVALIN A; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; LIVER CELL; LIVER INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0032080399     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI504     Document Type: Article

References (37)

1. Diehl, A.M., and R.M. Rai. 1996. Regulation of signal transduction during liver regeneration. FASEB (Fed. Am. Soc. Exp. Biol.) J. 10:215-227.
2. Tiegs, G., J. Hentschel, and A. Wendel. 1992. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90:196-203.
3. Gantner, F., M. Leist, A.W. Lohse, P.G. Germann, and A. Tiegs. 1995. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology. 21:190-198.
4. Mizuhara, H., E. O'Neill, N. Seki, T. Ogawa, C. Kusunoki, K. Otsuka, S. Satoh, M. Niwa, H. Senoh, and H. Fujiwara. 1994. T-cell activation-associated hepatic injury: mediation by tumor necrosis factor and protection by interleukin 6. J. Exp. Med. 179:1529-1537.
5. + LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis. Hepatology. 24:1416-1421.
6. Ferrari, C., M.U. Mondelli, A. Penna, F. Fiaccadori, and F.V. Chisari. 1987. Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines. J. Immunol. 139:539-544.
7. + T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus virus mutants. Hepatology. 22:61-68.
8. Napoli, J., G.A. Bishop, P.H. McGuiness, D.M. Painter, and G.W. McCaughan. 1996. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology. 24:759-765.
9. Küsters, S., F. Gantner, G. Künstle, and G. Tiegs. 1996. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology. 111:462-171.
10. Cressman, D.E., L.E. Greenbaum, R.A. DeAngelis, G. Ciliberto, E.E. Furth, V. Poli, and R. Taub. 1996. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science. 274:1379-1383.
11. Akerman, P.A., P. Cote, S.Q. Yang, C. McClain, S. Nelson, G.J. Bagby, and A.M. Diehl. 1992. Antibodies to tumor necrosis factor-α inhibit liver regeneration after partial hepatectomy. Am. J. Physiol. 263:G579-G585.
12. Akira, S., Y. Nishio, M. Inoue, X.-J. Wang, S. Wei, T. Matsusaka, K. Yoshida, T. Sudo, M. Naruto, and T. Kishimoto. 1994. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell. 77:63-71.
13. Zhong, Z., Z. Wen, and J.E. Darnell. 1994. Stat3: a Stat family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science. 264:95-98.
14. Cressmann, D.E., R.H. Diamond, and R. Taub. 1995. Rapid activation of the Stat3 transcription complex in liver regeneration. Hepatology. 21:1443-1449.
15. Trautwein, C., T. Rakemann, M. Niehof, S. Rose-John, and M.P. Manns. 1996. APRF, increased binding and target gene activation during liver regeneration. Gastroenterology. 110:1854-1862.
16. Diehl, A.M., M. Yin, J. Fleckenstein, S.Q. Yang, H.Z. Lin, D.A. Brenner, J. Westwick, G. Bagby, and S. Nelson. 1994. Tumor necrosis factor-α induces c-jun during the regenerative reponse to liver injury. Am. J. Physiol. 267: G552-G561.
17. Diehl, A.M., S.Q. Yang, M. Yin, H.Z. Lin, S. Nelson, and G. Bagby. 1995. Tumor necrosis factor-alpha modulates CCAAT/enhancer binding proteins-DNA binding activities and promotes hepatocyte-specific gene expression during liver regeneration. Hepatology. 22:252-261.
18. Trautwein, C., T. Rakemann, A. Pietrangelo, J. Plumpe, G. Montosi, and M.P. Manns. 1996. C/EBP-β/LAP controls downregulation of albumin gene transcription during liver regeneration. J. Biol. Chem. 271:22262-22270.
19. Trautwein, C., D. Walker, J. Plümpe, and M.P. Manns. 1995. Transactivation of LAP/NF-IL6 is mediated by an acidic domain in the N-terminal part of the protein. J. Biol. Chem. 270:15130-15136.
20. Trautwein, C., C. Caelles, P. van der Geer, T. Hunter, M. Karin, and M. Chojkier. 1993. Transactivation by LAP/NF-IL6 is enhanced by phosphorylation of its activation domain. Nature. 364:544-547.
21. Bock, C.T., H.L. Tillmann, H. Maschek, M.P. Manns, and C. Trautwein. 1997. A preS mutation isolated from a patient with chronic hepatitis B infection leads to virus retention and misassembly. Gastroenterology. 113:1976-1982.
22. Leist, M., F. Gantner, S. Jilg, and A. Wendel. 1995. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J. Immunol. 154:1307-1316.
23. Sherr, C.J. 1993. Mammalian G1 cyclins. Cell. 73:1059-1065.
24. Wegner, M., Z. Cao, and M.G. Rosenfeld. 1992. Calcium-regulated phosphorylation within the leucine zipper of C/EBPβ. Science. 256:370-373.
25. Williams, S.C., M. Baer, A.J. Dillner, and P.F. Johnson. 1995. CRP2 (C/EBPβ) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity. EMBO (Eur. Mol. Biol. Organ.) J. 14:3170-3183.
26. Horvath, C.M., Z. Wen, and J.E. Darnell. 1995. A Stat protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev. 9:984-994.
27. Yamada, Y., I. Kirillova, J.J. Peschon, and N. Fausto. 1997. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type T tumor necrosis factor receptor. Proc. Natl. Acad. Sci. USA. 94:1441-1446.
28. Buck, M., H. Turler, and M. Chojkier. 1994. LAP (NF-IL-6), a tissue-specific transcriptional activator, is an inhibitor of hepatoma cell proliferation. EMBO (Eur. Mol. Biol. Organ.) J. 13:851-860.
29. Barone, M.V., A. Crozat, A. Tabaee, L. Philipson, and D. Ron. 1994. CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. Genes Dev. 8:453-464.
30. Yin, M., S.Q. Yang, H.Z. Lin, M.D. Lane, S. Chatterjee, and A.M. Diehl. 1996. Tumor necrosis factor a promotes nuclear localization of cytokine-inducible CCAAT/enhancer binding protein isoforms in hepatocytes. J. Biol. Chem. 271:17974-17978.
31. Hsu, H., H.-B. Shu, M.-G. Pan, and D.V. Goedell. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 84:299-308.
32. Liu, Z-G., H. Hsu, D.V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell. 87:565-576.
33. Leist, M., F. Gantner, I. Bohlinger, P.G. German, G. Tiegs, and A. Wendel. 1994. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. J. Immunol. 153:1778-1787.
34. Wen, Z., Z. Zhong, and J.E. Darnell. 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell. 82:241-250.
35. Fukada, T., M. Hibi, Y. Yamanaka, M. Takahashi-Tezuka, Y. Fujitani, T. Yamaguchi, K. Nakajima, and T. Hirano. 1996. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of Stat3 in anti-apoptosis. Immunity. 5:449-460.
36. Bromberg, J.F., C.M. Horvath, Z. Wen, R.D. Schreiber, and J.E. Darnell. 1996. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon α and interferon γ. Proc. Natl. Acad. Sci. USA. 93:7673-7678.
37. Darnell, J.E., I.M. Kerr, and G.R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 264:1415-1421.